BeiGene, Ltd. Cash Flow-to-Debt Ratio
BeiGene, Ltd. cash flow-to-debt ratio. BeiGene, Ltd. (ONC) has a Cash Flow-to-Debt Ratio of 0.05x as of March 2026, meaning its operating cash flow of $201.94 Million could theoretically repay 0% of its total liabilities ($3.79 Billion) in one year. Check earnings quality score of BeiGene, Ltd. to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of BeiGene, Ltd. (2013–2025)
Cash flow-to-debt ratio of BeiGene, Ltd. from 2013 to 2025. Historical debt coverage capacity for BeiGene, Ltd. across 13 annual periods. Check ONC cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
BeiGene, Ltd. Cash Flow-to-Debt Ratio by Year (2013–2025)
BeiGene, Ltd. cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for BeiGene, Ltd.. For the full cash flow conversion analysis, see BeiGene, Ltd. operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.29x | $1.13 Billion | $3.83 Billion | ▲ +642.3% |
| 2024 | -0.05x | $-140.63 Million | $2.59 Billion | ▲ +89.4% |
| 2023 | -0.51x | $-1.16 Billion | $2.27 Billion | ▲ +31.9% |
| 2022 | -0.75x | $-1.50 Billion | $2.00 Billion | ▼ -38.7% |
| 2021 | -0.54x | $-1.30 Billion | $2.40 Billion | ▲ +27.1% |
| 2020 | -0.74x | $-1.28 Billion | $1.73 Billion | ▲ +37.4% |
| 2019 | -1.18x | $-750.27 Million | $633.93 Million | ▼ -7.2% |
| 2018 | -1.10x | $-547.72 Million | $496.04 Million | ▼ -3236.7% |
| 2017 | 0.04x | $12.75 Million | $362.25 Million | ▲ +102.1% |
| 2016 | -1.69x | $-89.51 Million | $52.91 Million | ▼ -80.2% |
| 2015 | -0.94x | $-39.84 Million | $42.45 Million | ▼ -200.7% |
| 2014 | -0.31x | $-8.69 Million | $27.85 Million | ▼ -473.7% |
| 2013 | 0.08x | $4.07 Million | $48.76 Million | — |